Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, November 1999, p. 2720-2725, Vol. 43, No. 11
Service de Microbiologie,
Received 14 May 1999/Returned for modification 20 July
1999/Accepted 31 August 1999
Quinupristin-dalfopristin is a streptogramin combination active
against multiply resistant Enterococcus faecium. Among 45 E. faecium isolated from patients in various French
hospitals, only two strains were intermediate (MIC = 2 µg/ml)
and one, E. faecium HM1032, was resistant (MIC = 16 µg/ml) to quinupristin-dalfopristin, according to British Society for
Antimicrobial Chemotherapy and National Committee for Clinical
Laboratory Standards approved breakpoints. The latter strain contained
the vgb and satA genes responsible for
hydrolysis or acetylation of quinupristin and dalfopristin,
respectively, and an ermB gene (also previously referred to
as ermAM) encoding a ribosomal methylase. The two intermediate strains had an LSA phenotype characterized by
resistance to lincomycin (L), increased MICs (
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Effects of Genes Encoding Resistance to
Streptogramins A and B on the Activity of Quinupristin-Dalfopristin
against Enterococcus faecium
8 µg/ml) of
dalfopristin (streptogramin A [SA]), and susceptibility
to erythromycin and quinupristin. This phenotype was also detected in
eight other strains susceptible to quinupristin-dalfopristin. No genes
already known and conferring resistance to dalfopristin by acetylation
or active efflux were detected in these LSA strains.
Nineteen other strains resistant to erythromycin but susceptible to the
quinupristin-dalfopristin combination displayed elevated MICs of
quinupristin after induction (from 16 to >128 µg/ml) and contained
ermB genes. The effects of ermB,
vgb, and satA genes on the activity of the
streptogramin combination were tested by cloning these genes
individually or in various combinations in recipient strains
susceptible to quinupristin-dalfopristin, E. faecium HM1070
and Staphylococcus aureus RN4220. The presence of both the
satA and vgb genes (regardless of the presence
of an ermB gene) was necessary to confer full
quinupristin-dalfopristin resistance to the host. The same genetic
constructs were introduced into E. faecium BM4107 which
displays a LSA phenotype. Addition of the satA
or vgb gene to this LSA background conferred
resistance to quinupristin-dalfopristin.
*
Corresponding author. Mailing address: CHU de Caen,
Service de Microbiologie, Avenue Côte de Nacre, 14033 Caen Cedex,
France. Phone: (33) 2 31 06 45 72. Fax: (33) 2 31 06 45 73. E-mail:
leclercq-r{at}chu-caen.fr.
Antimicrobial Agents and Chemotherapy, November 1999, p. 2720-2725, Vol. 43, No. 11
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |